Page 3 - ஆண்டு உலகளாவிய முதலீடு மாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionOppenheimer fall healthcare life sciences medtech summitTherapeutics incLigand pharmaceuticals incorporatedViking therapeuticsQuarter ended juneBrian lianAnnual biopharma virtualAnnual global investment conferenceSix month financial highlightsMonths ended juneLigand pharmaceuticalsSecurities litigation reform actAnnual reportQuarterly reportsபரிமாற்றம் தரகு

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva Reports First-Half of 2021 Financial Information

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva Reports First-Half of 2021 Financial Information
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United statesFrance generalCity ofUnited kingdomÎe de francePascaline clercYannick tetzlaffAude lepreuxPatricial bankCompany phaseBrunswick groupExchange commission onPortzamparc health biotech seminarBourse forumGlobal external affairsResearch tax credit

Hansa Biopharma to host conference call to provide interim results for first half 2021 and Business Update

Hansa Biopharma to host conference call to provide interim results for first half 2021 and Business Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomHansa biopharmaPrnewswire hansa biopharmaKlaus sindahlDonato spotaKatja margellHead of corporate communicationsDanske bank life scienceNasdaq stockholmWilliam blair biotech focus conferenceHandelsbanken life science innovation seminarPenser accessPareto healthcare conferenceMorganstanley global healthcare conferenceAnnual global investment conference

Enterome to Present at Upcoming Investor Conferences

Enterome to Present at Upcoming Investor Conferences
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

France generalPierre belichardSylvie berrebi markHead of external communicationsBiotechnology conferenceAnnual global investment conferenceExternal communicationsMark swallowHodgkinb cellதலை ஆஃப் வெளிப்புறம் தகவல்தொடர்புகள்உயிரி தொழில்நுட்பவியல் மாநாடுஆண்டு உலகளாவிய முதலீடு மாநாடுவெளிப்புறம் தகவல்தொடர்புகள்குறி விழுங்க

INVENTIVA: Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases

INVENTIVA: Inventiva reports first quarter 2021 financial information and updates on the collaboration with AbbVie in auto-immune diseases Revenues of €0.1m in Q1 2021 Decision by AbbVie to move into Phase IIb clinical development with cedirogant in psoriasis, following promising results in its Phase Ib clinical trial Daix (France), May 12, 2021 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today reported its cash position as of March 31, 2021 and its revenues for the first quarter of 2021, and provided an update on its collaboration with AbbVie in auto-immune diseases.

France generalCity ofUnited kingdomPascaline clercYannick tetzlaffAude lepreuxPatricial bankBrunswick groupExchange commission onGlobal external affairsPortzampac health biotech seminarInternational liver congressEuronext parisNon alcoholic fatty liver diseaseVirtual healthcare conferenceCyberx series